TYK2 Inhibitor Compound, BeOne Medicines, US12606556B2
Summary
The USPTO granted Patent US12606556B2 to BeOne Medicines I GmbH on April 21, 2026, covering a TYK2 inhibitor compound (Formula I) and its pharmaceutical uses for treating inflammatory or autoimmune diseases. The patent contains 17 claims and classifies under CPC C07D 471/04. Inventors are Qiuwen Wang, Yunhang Guo, and Zhiwei Wang. The patent creates intellectual property rights but does not impose compliance obligations on third parties.
What changed
The USPTO issued Patent US12606556B2 to BeOne Medicines I GmbH covering a TYK2 inhibitor compound of Formula (I), methods of using the compound to inhibit TYK2, and methods of treating TYK2-related inflammatory or autoimmune diseases. The patent includes 17 claims and classifies under C07D 471/04.
Pharmaceutical companies developing JAK family kinase inhibitors or therapies targeting inflammatory and autoimmune diseases should review this patent for freedom-to-operate considerations. Parties seeking to develop or commercialize TYK2 inhibitors for similar therapeutic applications may need to evaluate potential licensing or design-around options.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TYK-2 inhibitor
Grant US12606556B2 Kind: B2 Apr 21, 2026
Assignee
BeOne Medicines I GmbH
Inventors
Qiuwen Wang, Yunhang Guo, Zhiwei Wang
Abstract
Disclosed herein is a compound of Formula (I) for inhibiting TYK2 and treating disease associated with undesirable tyk-2 activity (tyk-2 related diseases), a method of using the compounds disclosed herein for treating inflammatory or autoimmune disease, and a pharmaceutical composition comprising the same.
CPC Classifications
C07D 471/04
Filing Date
2021-02-25
Application No.
17801551
Claims
17
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.